Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2007 | 1 |
2009 | 1 |
2010 | 2 |
2011 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release.
Retrovirology. 2011 Feb 10;8:9. doi: 10.1186/1742-4690-8-9.
Retrovirology. 2011.
PMID: 21310048
Free PMC article.
Modulation of HIV-1-host interaction: role of the Vpu accessory protein.
Dubé M, Bego MG, Paquay C, Cohen ÉA.
Dubé M, et al.
Retrovirology. 2010 Dec 22;7:114. doi: 10.1186/1742-4690-7-114.
Retrovirology. 2010.
PMID: 21176220
Free PMC article.
Review.
Item in Clipboard
The Vpu protein: new concepts in virus release and CD4 down-modulation.
Ruiz A, Guatelli JC, Stephens EB.
Ruiz A, et al.
Curr HIV Res. 2010 Apr;8(3):240-52. doi: 10.2174/157016210791111124.
Curr HIV Res. 2010.
PMID: 20201792
Free PMC article.
Review.
Item in Clipboard
Strategies for inhibiting function of HIV-1 accessory proteins: a necessary route to AIDS therapy?
Richter SN, Frasson I, Palù G.
Richter SN, et al.
Curr Med Chem. 2009;16(3):267-86. doi: 10.2174/092986709787002646.
Curr Med Chem. 2009.
PMID: 19149577
Review.
Item in Clipboard
Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation.
Butticaz C, Michielin O, Wyniger J, Telenti A, Rothenberger S.
Butticaz C, et al.
J Virol. 2007 Feb;81(3):1502-5. doi: 10.1128/JVI.01711-06. Epub 2006 Nov 22.
J Virol. 2007.
PMID: 17121803
Free PMC article.
Item in Clipboard
Cite
Cite